4 vs 6 Implants in Totally Edentulous Patient in Maxilla With Ti. Cad-cam Framework
Primary Purpose
Edentulous Maxilla
Status
Active
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
4 vs 6 implant treatment in the maxilla
Sponsored by
About this trial
This is an interventional treatment trial for Edentulous Maxilla focused on measuring Implantology, oral surgery, bone level changes, marginal bone level
Eligibility Criteria
Inclusion Criteria:
Inclusion criteria:
- age > 18 years;
- edentulous maxilla or having hopeless remaining teeth that are intended to be extracted;
- willingness to comply with all study requirements and to sign the IC;
- have sufficient amount of bone (8mm or more) in the recipient site to allow implant placement without bone augmentation procedures.
Exclusion Criteria:
- bone defects associated with severe knife-edge ridges;
- bone defects resulting from tumor resection;
- tobacco abuse (> 10 cigarettes/day);
- severe kidney and liver disease;
- history of radiotherapy in the head and neck region;
- chemotherapy for treatment of malignant tumors at the time of the surgical procedure;
- uncontrolled diabetes;
- active periodontal disease involving the residual opposite dentition;
- mucosal disease, such as lichen planus, in the areas to be treated;
- poor oral hygiene;
- non-compliant patients;
- situations judged inconvenient(by the investigator) for the surgical treatment.
Sites / Locations
- Franci Institute
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Test -4 implants-
Control -6 implants-
Arm Description
Evaluate marginal bone level (MBL) changes at implants that are placed in total edentulous patient when they are treated with four with titanium Cad/Cam framework.
Evaluate marginal bone level (MBL) changes at implants that are placed in total edentulous patient when they are treated with six with titanium Cad/Cam framework
Outcomes
Primary Outcome Measures
Marginal bone resorption in millimeter from the the implant to the bone crest.
Marginal bone resorption in millimeter from the the implant to the bone crest.
Marginal bone resorption in millimeter from the the implant to the bone crest.
Secondary Outcome Measures
Fracture of the prosthetic components
Fracture of the prosthetic components
Fracture of the prosthetic components
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02405169
Brief Title
4 vs 6 Implants in Totally Edentulous Patient in Maxilla With Ti. Cad-cam Framework
Official Title
Four Versus Six Endosseous Implants to be Used in the Rehabilitation of Totally Edentulous Patient in the Maxilla With Titanium Milled Framework
Study Type
Interventional
2. Study Status
Record Verification Date
September 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
December 2013 (undefined)
Primary Completion Date
March 2017 (Actual)
Study Completion Date
September 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Institute Franci
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The primary objective of the present study is to evaluate the marginal bone level changes occurring in total edentulous patients treated with six or four implants.
Secondary objective
overall survival rate
soft tissue status by assessment of bleeding on probing (BoP) and probing pocket depth (PPD) at baseline and after 1,3,5 years
prosthetic survival rates including screw or abutment loosening, framework or veneer fractures
Detailed Description
METHODS/PROCEDURES A randomized controlled multi-center clinical study is designed to determine whether a difference exists between the outcome of treatment when Astra tech implants are placed according to a six or a four implants protocol. The investigation will be performed in four centers: three in Italy affiliated to Institute Franci and one affiliated to the Department of Prosthodontics, Faculty of Odontology, Malmö University. In each center the clinician and the examiner will be the same person. The study protocol will be approved by the Regional Human Review Board of Padova General Hospital.
An investigators' meeting will be arranged prior to the starting with the patients' recruitment. Following a screening examination, subjects who will meet the inclusion criteria, will sign the Informed Consent and will be enrolled in the study. The period of patient enrollment will begin on January 1 2013 and ends December 31 2013.
The patients will be randomized with a method based on the use of sealed opaque envelopes. The cases will be assigned to two different treatment groups:
Group A- four implants (Test) Group B- six implants (Control)
Pre-treatment Patient data, medical history, clinical and radiographic examination will be recorded for each patient. Clinical photographs will be taken in frontal, occlusal and lateral projections.
Periodontal, endodontic and open caries lesions will be treated prior to implant installation. All patients will receive careful oral hygiene instructions and training in self-performed
plaque control measure. CT scan computed exams will be carried out. Plaster models and diagnostic wax-up will be carried out.
First Surgical Phase (Implant Installation) The patient will receive antibiotic prophylaxis (Amoxicillin 1gr) one hour prior to surgery and after the completion of implant installation until suture removal with 1gr three times a day. (If the patient is allergic to amoxicillin the examiner prescribes antibiotics at his own discretion at the same posology).
The surgical treatment will be performed under local anesthesia. In case of remaining teeth, they will be extracted with conventional technique before implants' placement. (13-14) Implants will be placed according to the guidelines described in the Astra Tech® manual "Surgical procedures", using a two-stage protocol.
Implant spinning during the positioning of the cover screw will be registered as positive, if present, or negative.
The operation will be finalized by a careful adaption of the flaps by means of an accurate suture in order to obtain a full periosteal coverage.
Intraoral clinical photographs before, during and after surgery will be taken.
Post-operative care The patients will be instructed to rinse with chlorhexidine 0.12% mouthrinse and will be told to rinse with the antiseptic solution three times a day for 2 weeks. The patients will be advised to take NSAIDs for pain relief at their own discretion.
Liquid and semisolid food will be prescribed for the first post-operative week, after which the sutures will be removed.
Two weeks after the operation the denture will be properly relined until the second stage surgery.
Patients will be controlled at third and sixth weeks.
Second surgical phase and Prosthetic procedures After eight weeks (+ 2) of healing in both groups (A and B) Uni Abutment 45° connection procedure will be performed. Impression with a customized spoon and Impregum material will be taken and the prosthetic procedure will be performed according to the Atlantis-Isus recommendations.
After 6 weeks (+ 2) from Uni Abutment connection the definitive full-arch fixed dental prostheses screw retained will be applied. The prosthesis will be made to accomplish the normal hygienic procedures. All prosthetic procedures will be made in accordance to the Astra Tech procedures & products manuals.
The length of bridge cantilevers will be duly calculated to minimize implant overloading according to the Atlantis-Isus recommendations (15)
Post-prosthetic measurements Clinical measurements Clinical examinations will be performed immediately following the installation of the definitive prosthesis (Baseline-Loading) and after 1, 3, and 5 years. In particular, plaque and soft-tissue inflammation will be registered. Clinical photographs will be taken at each interval point.
Plaque: the presence of plaque will be scored at each implant site as well as at level of the remaining teeth on four surfaces (buccal, lingual/palatal, mesial, distal). The mean percentage of plaque harboring surfaces will be calculated using the case as the unit.
Soft-tissue inflammation: the presence of soft-tissue inflammation (bleeding on probing) will be assessed on buccal, lingual/palatal, mesial, distal aspects of each implant. The mean percentage of inflamed sites will be calculated using the case as the unit.
Radiographic measurements Peri-apical radiographs will be taken at prosthesis insertion (Baseline) and after 1, 3, and 5 years.
The radiographs will be taken with an X-ray apparatus supplied with a long cone by the examiner each visiting time. Rinn centrators will be used to ensure reproducibility in the measurement of marginal bone level change.
The radiographic images will be analysed at the Department of Radiology of Sahlgrenska Academy, Gothenburg University by experienced radiologists who will be otherwise not involved in the study.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Edentulous Maxilla
Keywords
Implantology, oral surgery, bone level changes, marginal bone level
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
56 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Test -4 implants-
Arm Type
Experimental
Arm Description
Evaluate marginal bone level (MBL) changes at implants that are placed in total edentulous patient when they are treated with four with titanium Cad/Cam framework.
Arm Title
Control -6 implants-
Arm Type
Active Comparator
Arm Description
Evaluate marginal bone level (MBL) changes at implants that are placed in total edentulous patient when they are treated with six with titanium Cad/Cam framework
Intervention Type
Device
Intervention Name(s)
4 vs 6 implant treatment in the maxilla
Other Intervention Name(s)
Astratech TX implant , Densply Implant (company name)
Primary Outcome Measure Information:
Title
Marginal bone resorption in millimeter from the the implant to the bone crest.
Time Frame
1 year
Title
Marginal bone resorption in millimeter from the the implant to the bone crest.
Time Frame
3 year
Title
Marginal bone resorption in millimeter from the the implant to the bone crest.
Time Frame
5 year
Secondary Outcome Measure Information:
Title
Fracture of the prosthetic components
Time Frame
1 year
Title
Fracture of the prosthetic components
Time Frame
3 year
Title
Fracture of the prosthetic components
Time Frame
5 year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Inclusion criteria:
age > 18 years;
edentulous maxilla or having hopeless remaining teeth that are intended to be extracted;
willingness to comply with all study requirements and to sign the IC;
have sufficient amount of bone (8mm or more) in the recipient site to allow implant placement without bone augmentation procedures.
Exclusion Criteria:
bone defects associated with severe knife-edge ridges;
bone defects resulting from tumor resection;
tobacco abuse (> 10 cigarettes/day);
severe kidney and liver disease;
history of radiotherapy in the head and neck region;
chemotherapy for treatment of malignant tumors at the time of the surgical procedure;
uncontrolled diabetes;
active periodontal disease involving the residual opposite dentition;
mucosal disease, such as lichen planus, in the areas to be treated;
poor oral hygiene;
non-compliant patients;
situations judged inconvenient(by the investigator) for the surgical treatment.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Denis Cecchinato, DDS
Organizational Affiliation
Franci Institute
Official's Role
Study Director
Facility Information:
Facility Name
Franci Institute
City
Padova
ZIP/Postal Code
35121
Country
Italy
12. IPD Sharing Statement
Learn more about this trial
4 vs 6 Implants in Totally Edentulous Patient in Maxilla With Ti. Cad-cam Framework
We'll reach out to this number within 24 hrs